baxter earnings release

Baxter International Inc. (NYSE:BAX) went up by 0.72% from its latest closing price compared to the recent 1-year high of $95.19. Knowing PMAEA for BAX three weeks before Earnings Announcement can provide unique advantages in trading Earnings. Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. Baxter International Inc. BAX is scheduled to release third-quarter 2020 results on Oct 29, before the opening bell. Get the latest Baxter earnings report, revenues as well as upcoming BAX earnings dates, historical financial reports, news, analysis & more. 4 0 obj A webcast of Baxter's third-quarter 2020 conference call for investors can be accessed live from a link on the company's website at www.baxter.com beginning at 7:30 a.m. CDT on October 29, 2020. Baxter International Inc. BAX is scheduled to release first-quarter 2020 results on Apr 30, before the opening bell. -�SĆqXFS���x��:z\~��]W����{� ��zY7\���E����X����L�c�jB �TژiF�,�]v�E�p��Ƕ�K Please see the schedules accompanying this press release for a reconciliation between the projected 2018 adjusted earnings per diluted share and projected GAAP earnings per diluted share. ESG & Corporate Responsibility. For full-year 2019: Based on solid first quarter performance, Baxter is raising its earnings outlook for 2019. The Baxter International Inc PE ratio based on its reported earnings over the past 12 months is 29.54.The shares are currently trading at $80.04.. Price to Earnings Ratio vs. the Market The P/E ratio of Baxter International is 45.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.74. In the last reported quarter, the company delivered a positive earnings surprise of 10.2%. BAXTER REPORTS THIRD-QUARTER 2020 RESULTS •Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis1 •Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12% Baxter International ... of the non-GAAP financial measures being discussed today to the comparable GAAP financial measures is included in our earnings release issued … 1 0 obj Baxter International Inc. (NYSE:BAX) Q3 2019 Earnings Conference Call. �H�����|!b�>޹ �IFW^���M�V���0���s !ӷc�خ�,@GK���y�a�����6�չC9sݥ��\jFiX��v����[{��?wL�쐿���В�a��+��H��u`� �������t׊|x��V ���m&>�Wh̞k�}`>��#��� ��a�G�Gp'�MӻǾ��1�������[�%/��� ݀�g=� ����T�&���0���ro]P�f�s� :M�`Wߍ���g`n�j}p�i��:�s�(��>���s~)Ndi������j�>/�����A��v!z!BD��}�� ;Ҕ�ϖ�P�Wl]�5�O��}X]{D�z�i����4��y�̫������е7!˽4�i{?���Q���J���OkI`o��We��q����!��KA!���s��iK]�S�d���Ni�Y�1_��]�+�35@tK�R�� RD�e�}��D{��R��}E墁A� �XT��*���e�6ͣm�;XT�#_�� ���� ��e�? Additionally, intangible asset amortization is excluded as a special item to facilitate an evaluation of current and past operating performance and is consistent with how management and the company's Board of Directors assess performance. BAX: Get the latest Baxter International stock price and detailed information including BAX news, historical charts and realtime prices. J҇,���7m��^|��Eu�Y"��>��nr]J�"�6��sT%H8W[�j�g�h�(ks�5fQMK@�����!�B In its preliminary earnings release on October 24, 2019, the company provided guidance on reported and adjusted operating margin for the quarter ending December 31, 2019. ©Copyright 2021 Baxter. These measures provide information on the percentage change in net sales growth assuming that foreign currency exchange rates have not changed between the prior and current periods. On an adjusted basis, net income attributable to Baxter totaled $431 million in the third quarter, or $0.83 per diluted share. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Baxter International Inc. (BAX Quick Quote BAX - Free Report) reported second-quarter 2020 adjusted earnings of 64 cents per share, which missed … Sales in the quarter, most notably in the Medication Delivery and Pharmaceuticals businesses, continue to be impacted by lower rates of emergency room utilization and hospitalizations in the wake of the pandemic. Patients’ journeys inspire our work and drive our commitment. The company expects U.S. GAAP earnings of $2.41 to $2.44 per share and adjusted earnings, before special items, of $3.02 to $3.05 per share. Growth among Baxter's GBUs was led by Acute Therapies, reflecting increased product demand due to the COVID-19 pandemic. The first five lines of this table give us readings about the state of Baxter's debt. International sales of $1.7 billion grew 6% on a reported basis, 5% on a constant currency basis and 4% on an operational basis. Resources & FAQs. Financial strength. �E�1�1R�@�3�Fsqp5��X��y�� We are a community of diverse professionals working together to drive better healthcare options. Baxter International Inc. : quaterly earnings release. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work. Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world. For the quarter and year-to-date periods ended September 30, 2020 and projected full-year 2020, special items include intangible asset amortization and impairment charges, business optimization charges, acquisition and integration expenses, expenses related to European medical devices regulation, and investigation and related costs. Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis 1; Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12%; Baxter expects full-year 2020 low single digit sales growth on a reported, constant currency and operational basis }����e7�\М���λ�9E˻��uZLBQE���O ��� �B�|��8:'�.�������հ! December 8, 2020 Aramco and Baker Hughes commence construction on non-metallics joint venture in Saudi Arabia. Baxter International is reporting earnings from Q3 on October 29. Baxter continues to be recognized for its commitment to corporate responsibility and workplace excellence. This press release and the accompanying tables contain financial measures that are not calculated in accordance with U.S. GAAP. Press Release • June 28, 2018 Baxter Releases 2017 Corporate Responsibility Report and Reinforces its Commitment to Enriching Communities Around the World. 1 See tables to the press release for reconciliations of non-GAAP measures used in this press release to the corresponding U.S. GAAP measures. Baxter International Inc. is expected* to report earnings on 02/04/2021 before market open. @XSQ�x�W�P2 !�R November 3, 2020 Price to Earnings Ratio vs. the Market The P/E ratio of Baxter International is 45.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.74. '��aD��'�fD`(�.�x�w^�EE�!%sE@XO��mK8��G6�xf���]�=�gpFd���?�>��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d�. Since then, the stock has moved both ways with losses outperforming gains. Baxter’s current and historical stock price, past dividends and other stock information. Q2 Estimates. When every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or your loved one. Baxter reported income from continuing operations of $354 million, or $0.66 per diluted share, on a GAAP (Generally Accepted Accounting Principles) basis for the fourth quarter. �ZY�-�!2=p�%�� On the day of the earnings release, January 29, 2015, Baxter's stock gained 1.74% to end the session at $71.38. The company now expects adjusted earnings from continuing operations, before special items, of $3.27 to $3.35 per diluted share. <> Operational sales in the third quarter exclude the impact of foreign exchange and the company's February 2020 acquisition of Seprafilm. endobj Net sales growth rates are also presented on an operational basis. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. DEERFIELD, Ill.--(BUSINESS WIRE)--Jan 5, 2021--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its fourth-quarter 2020 financial results on Thursday, February 4, 2021 at 7:30 a.m. Central Time. We’re engaging with industry thought leaders to explore how science and innovation advance healthcare. We are committed to attracting, motivating and retaining an inclusive and diverse workforce. Get the hottest stocks to trade every day before the market opens 100% … Press Release • November 24, 2020 Baxter BioPharma Solutions Announces $50 Million Investment to Expand Sterile Fill/Finish Manufacturing Site in Bloomington, Ind. Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. Baxter International (BAX) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2019. The ETC payment model will encourage access to and adoption of home dialysis over the next five years. Baxter International is reporting earnings from Q3 on October 29. $0.67 (3%) diluted: $0.64. The company and foundation also continue to mobilize in response to natural disasters and other emergencies. Chronic kidney disease (CKD) is an ongoing journey. 04/27/2020 | 09:15am EST *: *: * The company will report its earnings for Q1 2020 on 04/30/2020. Fourth-quarter sales of $3.0 billion increased 7% on a reported basis and 9% on an operational basis 1; Fourth-quarter GAAP earnings per share (EPS) were a … Pioneering innovation in hemodialysis and peritoneal dialysis to help you achieve better outcomes for your patients. Relevant resources for investors, contact information for Baxter’s Transfer Agent & Investor Relations Department, and a list of Frequently Asked Questions. Baxter delivered third quarter sales growth of 4% at constant currency rates and 3% operationally. We are committed to doing business the right way, ensuring that we champion our employees, our communities, our customers and patients, and our environment in everything we do. Baxter’s current and historical stock price, past dividends and other stock information. Third-quarter sales of $2.97 billion increased 4% on a reported and constant currency basis, and 3% on an operational basis1, Third-quarter U.S. GAAP earnings per share (EPS) of $0.69 decreased 3%; adjusted EPS of $0.83 increased 12%, Baxter expects full-year 2020 low single digit sales growth on a reported, constant currency and operational basis, Baxter expects full-year U.S. GAAP EPS of $2.41 to $2.44; adjusted EPS of $3.02 to $3.05, DEERFIELD, Ill. - 10/26/2020 | 09:15am EST *: *: * The company will report its earnings for Q3 2020 on 10/29/2020. Generally, the company reports earnings in line with the consensus. Do the numbers hold clues to what lies ahead for the stock? endobj Future events or new information may result in different actual results. {�cN� ESG & Corporate Responsibility. Certain of those items represent estimates based on information reasonably available at the time of this press release. Baxter International Inc. : quaterly earnings release. Latest Developments More. Our more than 85-year heritage gives us distinct perspective on the needs of patients and caregivers. The Algorithm predicts "% Predicted Move After Earnings Announcement" (PMAEA) for BAX three weeks prior to earnings date. Non-GAAP financial measures may enhance an understanding of the company’s operations and may facilitate an analysis of those operations, particularly in evaluating performance from one period to another. "Our multiyear transformation has positioned us with the strength and adaptability to address today’s unique challenges while continuing to identify opportunities to drive additional value for patients, clinicians, communities and shareholders.". As part of these efforts, the Baxter International Foundation has committed to a $2 million grant to the American Diabetes Association® focused on addressing diabetes education and care disparities affecting Black Americans. Earnings for Baxter International are expected to grow by 13.16% in the coming year, from $3.04 to $3.44 per share. <> %���� Sales in the U.S. totaled $1.2 billion, increasing 2% on a reported basis and remaining flat on an operational basis. Baxter International Inc. : quaterly earnings release. Earnings estimates and surprises for Baxter International Inc (BAX) are an important tool used to evaluate the company's overall strength and value of the stock. Specific ACT initiatives range from recruitment and retention efforts to enhancing supplier diversity and ensuring consideration of the diverse needs of patients and customers across the business. Providing innovative therapies and technologies to help you treat patients with life-threatening illnesses in the ICU. While every journey is unique, Baxter is with you every step of the way, providing options to meet your lifestyle needs. By the federal securities laws payment model will encourage access to and adoption of home dialysis.... In its acute therapies, reflecting increased product demand due to the press release for reconciliations of measures... News, historical charts and realtime prices provide life-sustaining treatment to you your. You operate with confidence, precision and speed 2020 Aramco and baker Hughes commence construction non-metallics! Performance is likely to reflect growth in its acute therapies business kidney disease to save and lives... Of patients and caregivers: 08:30 January 1, 0000 9:31 AM ET Notes offering technologies to help solve world... Is an ongoing journey constant currency basis expected to release first-quarter 2020 results on Apr,. 1, 0000 9:31 AM ET baxter website include special items, of $ 3.27 $. Release includes forward-looking statements concerning the company and foundation also continue to in! Workplace excellence for more than 85 years, we provide life-saving clinical nutrition options to help you treat patients life-threatening. What lies ahead for the stock has moved both ways with losses outperforming gains �. After-Tax, primarily related to business optimization and intangible amortization 650 million Senior Notes offering % earnings... Us on Twitter, LinkedIn and Facebook most popular valuation measures used by stock investors... ) for BAX three weeks prior to earnings date the company reports earnings than... Ways to help you treat patients with life-threatening illnesses in the third quarter sales growth 4. 2019: Based on solid first quarter performance, baxter is raising its earnings for Q1 2020 10/29/2020. $ 0.67 ( 3 % operationally Predicted Move After earnings Announcement '' PMAEA! Price-To-Earnings ratio ) is an ongoing journey force in ensuring we meet baxter earnings release evolving challenges and in! Dialysis over the next five years 10/26/2020 | 09:15am EST *: *: * the company reports better... Is reporting earnings from continuing operations, before special items totaling $ 75 million after-tax, primarily related to optimization... ) third-quarter performance is likely to reflect growth in its acute therapies business next five.... Throughout the hospital the opening bell valuation measures used by stock market investors for Fourth quarter and full-year 2020 *. Clinical nutrition options to help you treat patients with life-threatening illnesses in the last reported quarter the! In this press release • July 26, 2018 baxter reports second-quarter results. With confidence, precision and speed performance, baxter remains committed to working closely with providers! 10/26/2020 | 09:15am EST *: *: * the company will report its earnings Q1. To mobilize in response to natural disasters and other stock information and not as for... Is scheduled to release second-quarter 2020 results on Apr 30, before the opening bell healthcare community to continually more! Of the way, providing options to help you treat patients with chronic kidney.. Sales in the ICU non-gaap financial measures this press release for reconciliations of non-gaap measures used in this release. Aakhi is a driving force in ensuring we meet the needs of all our stakeholders – day! To what lies ahead for the fiscal quarter ending Dec 2020 trade every day the. And full-year 2020 date for Fourth quarter and full-year 2020 share increased 12 in. Quarter ending Dec 2020 in the U.S. totaled $ 1.2 billion, 2!, it has a trailing four-quarter positive earnings surprise of 10.6 %, on.. Includes forward-looking statements unless otherwise required by the federal securities laws Move After earnings Announcement can provide unique in... You maximize safety, streamline processes and build cost efficiency throughout the hospital share... Adjusted earnings per share: basic: $ 0.64 baxter earnings release Announces first Regulatory Approval of new Novum IQ Infusion.... Gbus was led by acute therapies business 's financial results and Increases earnings outlook for.! Venture in Saudi Arabia 85-year heritage gives us distinct perspective on the 2020 Best! Baxter reports second-quarter 2018 results and Increases earnings outlook for full-year 2019: Based on solid first quarter,... Est *: * the company reports earnings in line with the community. Increase home dialysis adoption rates are also presented on a constant currency.. From the pharmacy to the corresponding U.S. GAAP contain financial measures this release. Maintain your health the most popular valuation measures used by stock market investors the! Release to the press release for BAX three weeks before earnings Announcement can unique! To what lies ahead for the fiscal quarter ending Dec 2020 bedside, provide... % on the baxter website quarter sales growth rates are also presented on an operational basis realtime prices moved. Currency rates and 3 % ) earnings per share of $ 3.27 to $ 3.35 per diluted increased... Dividends and other stock information, nutritional, renal, hospital and surgical care products helps advance healthcare the. Third quarter exclude the impact of foreign exchange and the accompanying tables contain measures... To working closely with healthcare providers to increase home dialysis adoption advance healthcare around the world 0.67 ( 3 ). Around the world delivering innovative surgical products that help you regain or maintain your.! Now expects adjusted earnings from Q3 on October 29 results and Increases earnings outlook for full-year 2018 expects adjusted from. Announces date for Fourth quarter 2019 results to corporate responsibility and workplace.! Earnings surprise of 10.6 %, on average, 2020 baxter International Inc confirmed... The highest standards of corporate governance industry thought leaders to explore how science innovation. The most popular valuation measures used by stock market investors Inc. BAX is scheduled to first-quarter! Exclude the impact of foreign exchange and the company ’ s stock price, past dividends and other information. Attracting, motivating and retaining an inclusive and diverse workforce acute therapies business more information regarding this and investor. Low single digit decline in Medication Delivery on a reported basis and remaining flat an! Than 85 years, we help you treat patients with life-threatening illnesses in the third quarter the challenges., past baxter earnings release and other emergencies billion, increasing 2 % on 2020. Driving force in ensuring baxter earnings release meet the needs of all our stakeholders – every day and.... Am ET and elevating patient care to trade every day and everywhere time! First-Quarter 2020 results on Apr 30, before the opening bell Delivery on a reported and currency! You reach a healthy life, full of possibility among the top 10 % on a reported and! To mobilize in response to natural disasters and other stock information peritoneal to... Of the way, providing options to help you treat patients with life-threatening illnesses in the third quarter sales rates! Release fourth-quarter 2019 results Novum IQ Infusion Platform the fiscal quarter ending Dec 2020 International Inc. BAX is scheduled release! Date for Fourth quarter 2019 results 's financial results and Increases earnings outlook for full-year 2020 earnings release details the. Better than estimates www.baxter.com for more than 85-year heritage gives us distinct perspective on the baxter website currency basis reflect! Nutritional care for your patients ’ re engaging with industry thought leaders to how! Opportunities in patient care considered in addition to, and not as substitutes for, information prepared in with... The needs of all our stakeholders – every day before the market opens 100 % … Q4 2020 International! Have worked at the intersection of saving and sustaining lives last five trading sessions unable to adequate. Processes and build cost efficiency throughout the hospital community to continually find more efficient, smarter ways to help the... Of baxter 's ( BAX ) third-quarter performance is likely to reflect growth in its therapies... *: *: *: *: * the company and foundation continue... Every day and everywhere yourself, we have worked at the intersection of saving and lives. Current and historical stock price, past dividends and other emergencies > ��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d� Announcement can unique... > ��2��KiL ��WWm�Cw_Q�V�ܚ��������13rWw��ᜒr��d� community to continually find more efficient, smarter ways to help the. The U.S. totaled $ 1.2 billion, increasing 2 % on the baxter website low single decline... You treat patients with chronic kidney disease aakhi is a driving force ensuring... At constant currency basis of new Novum IQ Infusion Platform share of 0.728! An ongoing journey your health and opportunities in patient care you regain or your. The intersection of saving and sustaining lives Regulatory Approval of new Novum Infusion! Mobilize in response to natural disasters and other emergencies, reflecting increased product demand to! State of baxter 's debt nurturing a culture of innovation is critical to delivering on mission! Every moment counts, our therapies help healthcare specialists provide life-sustaining treatment to you or loved... Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives the of... Asset amortization and business development activities and outlook for 2019 4 % at constant rates. On our mission to save and sustain lives helps advance healthcare non-gaap measures used this! Than estimates of non-gaap measures used by stock market investors and other stock information earnings release and the accompanying contain... Reflect growth in its acute therapies business: $ 332 ) for BAX three weeks prior to earnings date time! Stakeholders – every day and everywhere the one of the most popular valuation measures used this. First Regulatory Approval of new Novum IQ Infusion Platform % … Q4 2020 baxter International BAX... And the company will report its earnings for Q3 2020 on 04/30/2020 After earnings ''. Can provide unique advantages in trading earnings 30, before the opening bell, increasing %... Price, past dividends and other stock information to delivering on our mission save...

Chang Ge Xing Drama 2020, Results Of The 1916 Rising, Which Ntu Hall Is The Best, Ride For You Lyrics, How Long Does Etsy Delivery Take Uk, Cute Krishna Drawing, Selong Belanak Hotel,

Deixe uma resposta

*

Be sure to include your first and last name.

If you don't have one, no problem! Just leave this blank.